AU Patient Summary Implementation Guide
0.1.0-cibuild - CI Build
AU Patient Summary Implementation Guide
0.1.0-cibuild - CI Build
AU Patient Summary Implementation Guide, published by HL7 Australia. This guide is not an authorized publication; it is the continuous build for version 0.1.0-cibuild built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7au/draft-au-patient-summary/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
HL7 Australia has an overarching intellectual property policy in place. The HL7 Australia - Intellectual Property Policy document defines the HL7 Australia organisation position on many aspects related to the copyright, licensing, liabilities and usage of HL7 Australia FHIR Implementation Guides. This also includes how the HL7 Australia FHIR Implementation Guides referencing other underlying material from HL7 International and 3rd parties shall be considered when using HL7 Australia published material. This policy document is maintained with the current official position of HL7 Australia with respect to these considerations.
HL7 FHIR® Licensing and Legal Terms should also be referenced as the underlying standards published terms on which HL7 Australia FHIR Implementation Guides depend.
A number of key considerations are included here to support HL7 Australia FHIR Implementation Guide usage.
HL7 Australia provides HL7 Australia content for informational and reference purposes. While HL7 Australia and the broader HL7 community endeavour to ensure the accuracy and reliability of HL7 Australia content, to the extent permitted by law, HL7 Australia:
(a) makes no warranties, express or implied:
(i) that HL7 Australia content will not infringe upon any third-party intellectual property rights, including patents, copyrights, trademarks, or trade secrets; or
(ii) that HL7 Australia content is suitable, complete or applicable for any particular purpose or use contemplated by the User, and
(b) shall not be liable for any direct, indirect, incidental, special, consequential, or punitive damages arising out of or in connection with the use or reliance on HL7 Australia content.
By accessing or using HL7 Australia content, Users agree to indemnify and hold harmless HL7 Australia, its officers, directors, employees, agents, and contributors of HL7 Australia content from any claims, damages, losses, liabilities, costs, or expenses (including legal fees) arising out of or in connection with the User’s use of or reliance on HL7 Australia content.
HL7 International Protocol Specifications Copyright © 2011+ HL7.
This specification (including downloadable content) is based on HL7 Protocol Specifications produced by HL7 International under the terms of HL7® Governance and Operations Manual relating to Intellectual Property (Section 09, at the time this specification was published), specifically its copyright, trademark and patent provisions.
HL7 International has and will continue to enforce the copyrights it holds in the HL7 Protocol Specifications.
Most trademarks used in conjunction with HL7® products, services and activities are registered and/or owned by HL7 International, rather than by HL7 Australia, and their use is subject to the associated HL7 International IP policies and licensing terms.
HL7®, HEALTH LEVEL SEVEN®, FHIR® and the FHIR logo are trademarks owned by Health Level Seven International, registered with the United States Patent and Trademark Office.
HL7 Australia licenses use of some HL7 Australia content under Creative Commons license. Users may only rely on the terms of a Creative Commons licence where HL7 Australia has explicitly licensed the use of an Artefact under a Creative Commons licence and shall not presume that a Creative Commons licence applies to any other HL7 Australia content not explicitly covered by a Creative Commons licence.
HL7 Australia use of this specification is licensed under Creative Commons “No Rights Reserved” (CC0).
Copyright © 2012+ HL7 Australia
Intellectual property rights and trademarks are defined in full in the HL7 Australia - Intellectual Property Policy document.
HL7 Australia FHIR Implementation Guides contain and reference intellectual property owned by third parties (“Third Party IP”). Acceptance of these License Terms does not grant any rights with respect to Third Party IP. The licensee alone is responsible for identifying and obtaining any necessary licences or authorisations to utilise Third Party IP in connection with the specification or otherwise.
Following is a non-exhaustive list of third-party artefacts and terminologies that may require a separate licence:
| Artefact / Terminology | Statement |
| SNOMED CT | International Healthcare Terminology Standards Developing Organization (IHTSDO). Where this specification includes or references content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO) it is distributed by agreement between IHTSDO and HL7, or the Australian Digital Health Agency via NCTS terms. Implementer use of SNOMED CT is not covered by this agreement |
| DICOM | National Electrical Manufacturers Association (NEMA). This specification may reference content from DICOM, which is copyright NEMA, and distributed by agreement between NEMA/DICOM and HL7. Implementer use of DICOM is not covered by this agreement |
| Logical Observation Identifiers Names & Codes (LOINC) | This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc. |
| National Clinical Terminology Services (NCTS) | This material contains references to National Clinical Terminology Service artefacts these are Copyright © 2024 Australian Digital Health Agency, implementer user of this content are advised of the NCTS Terms of Use. |